6IB Analyst Ratings
Strong Buy
8 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
6IB Stock 12 Month Forecast
Average Price Target
€13.71
▲(39.85% Upside)
| Highest Price Target€16.45 | Average Price Target€13.71 | Lowest Price Target€11.70 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
J.P. Morgan
€12.36→€12.59
Buy
28.43%
Upside
Reiterated
04/30/26
CMB International Securities
€12.68
Buy
29.41%
Upside
Reiterated
03/30/26
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
J.P. Morgan
€12.36→€12.59
Buy
28.43%
Upside
Reiterated
04/30/26
CMB International Securities
€12.68
Buy
29.41%
Upside
Reiterated
03/30/26
Best Analysts Covering Innovent Biologics
3 Months
1 Year
Success Rate
10/12 ratings generated profit
Average Return
+33.00%
Copying Rebecca Liang's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +33.00% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
6IB Analyst Recommendation Trends
Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
6
7
9
10
9
Buy
11
15
12
8
5
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
17
22
21
18
14
Each month's total comprises the sum of three months' worth of ratings.
6IB Financial Forecast
6IB Stock Forecast FAQ
What is DE:6IB’s average 12-month price target, according to analysts?
Based on analyst ratings, Innovent Biologics’s 12-month average price target is 13.71.
What is DE:6IB’s upside potential, based on the analysts’ average price target?
Innovent Biologics has 39.85% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Innovent Biologics a Buy, Sell or Hold?
Innovent Biologics has a consensus rating of Strong Buy, which is based on 8 buy ratings, 0 hold ratings and 0 sell ratings.
What is Innovent Biologics’s share price target?
The average share price target for Innovent Biologics is 13.71. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €16.45 ,and the lowest forecast is €11.70. The average share price target represents 39.85% Increase from the current price of €9.8.
The highest analyst share price target is €16.45 ,and the lowest forecast is €11.70. The average share price target represents 39.85% Increase from the current price of €9.8.
What do analysts say about Innovent Biologics?
Innovent Biologics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Streets Analysts.
How can I buy shares of Innovent Biologics?
To buy shares of DE:6IB, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.